naltrexone and bd 1047

naltrexone has been researched along with bd 1047 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hayashi, SS; Kamei, J; Ohsawa, M1
Horishita, T; Inagaki, H; Kawasaki, T; Obara, G; Sata, T; Takahashi, K; Toyohira, Y; Tsutsui, M; Ueno, S; Yanagihara, N1

Other Studies

2 other study(ies) available for naltrexone and bd 1047

ArticleYear
Effect of acute topical application of +-pentazocine on the mechanical allodynia in diabetic mice.
    European journal of pharmacology, 2010, Sep-01, Volume: 641, Issue:1

    Topics: Administration, Topical; Animals; Diabetes Complications; Ethylenediamines; Male; Mice; Mice, Inbred ICR; Naltrexone; Nitric Oxide; Pentazocine; Receptors, Opioid, kappa; Receptors, sigma; Sigma-1 Receptor

2010
Pentazocine inhibits norepinephrine transporter function by reducing its surface expression in bovine adrenal medullary cells.
    Journal of pharmacological sciences, 2013, Volume: 121, Issue:2

    Topics: Adrenal Medulla; Analgesics, Opioid; Animals; Cattle; Cell Line; Cell Membrane; Cells, Cultured; Ethylenediamines; Fluoxetine; Gene Expression; Humans; Naltrexone; Narcotic Antagonists; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Pentazocine; Radionuclide Imaging

2013